Description
Health Canada is issuing this guidance for clinical trials in type 2 diabetes to provide clarification on the interpretation of the Canadian Diabetes Association Clinical Practice Guidelines (CDA-CPG)Footnote1 in relation to clinical trial applications under Part C, Division 5 of the Food and Drug Regulations.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada | HTML | Open resource | |
| Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada | HTML | Open resource |